BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28514307)

  • 1. Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: Case report and literature review.
    Li N; Xu Y; Li G; Yu T; Yao RE; Wang X; Wang J
    Medicine (Baltimore); 2017 May; 96(20):e6914. PubMed ID: 28514307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability: a case report.
    Winczewska-Wiktor A; Badura-Stronka M; Monies-Nowicka A; Nowicki MM; Steinborn B; Latos-Bieleńska A; Monies D
    BMC Neurol; 2016 Mar; 16():35. PubMed ID: 26968164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability.
    Dashti S; Salehpour S; Ghasemi MR; Sadeghi H; Rostami M; Hashemi-Gorji F; Mirfakhraie R; Yassaee VR; Miryounesi M
    Neurol Sci; 2022 Apr; 43(4):2859-2863. PubMed ID: 35099645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.
    Kuechler A; Willemsen MH; Albrecht B; Bacino CA; Bartholomew DW; van Bokhoven H; van den Boogaard MJ; Bramswig N; Büttner C; Cremer K; Czeschik JC; Engels H; van Gassen K; Graf E; van Haelst M; He W; Hogue JS; Kempers M; Koolen D; Monroe G; de Munnik S; Pastore M; Reis A; Reuter MS; Tegay DH; Veltman J; Visser G; van Hasselt P; Smeets EE; Vissers L; Wieland T; Wissink W; Yntema H; Zink AM; Strom TM; Lüdecke HJ; Kleefstra T; Wieczorek D
    Hum Genet; 2015 Jan; 134(1):97-109. PubMed ID: 25326669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency.
    Dubruc E; Putoux A; Labalme A; Rougeot C; Sanlaville D; Edery P
    Am J Med Genet A; 2014 Jun; 164A(6):1571-5. PubMed ID: 24668549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense variants in CTNNB1 can be associated with vitreoretinopathy-Seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotype.
    Rossetti LZ; Bekheirnia MR; Lewis AM; Mefford HC; Golden-Grant K; Tarczy-Hornoch K; Briere LC; Sweetser DA; Walker MA; Kravets E; Stevenson DA; Bruenner G; Sebastian J; Knapo J; Rosenfeld JA; Marcogliese PC; ; Wangler MF
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1542. PubMed ID: 33350591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals.
    Kharbanda M; Pilz DT; Tomkins S; Chandler K; Saggar A; Fryer A; McKay V; Louro P; Smith JC; Burn J; Kini U; De Burca A; FitzPatrick DR; Kinning E;
    Eur J Med Genet; 2017 Feb; 60(2):130-135. PubMed ID: 27915094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Phenotype and Genotype in CTNNB1 Syndrome: A Systematic Review of the Literature.
    Miroševič Š; Khandelwal S; Sušjan P; Žakelj N; Gosar D; Forstnerič V; Lainšček D; Jerala R; Osredkar D
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects.
    Wang H; Zhao Y; Yang L; Han S; Qi M
    Neurol Sci; 2019 Aug; 40(8):1701-1704. PubMed ID: 30929091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical characteristics of 24 mainland Chinese patients with CTNNB1 loss-of-function variants.
    Yan D; Sun Y; Xu N; Yu Y; Zhan Y;
    Mol Genet Genomic Med; 2022 Nov; 10(11):e2067. PubMed ID: 36153650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Exudative Vitreoretinopathy and Systemic Abnormalities in Patients With CTNNB1 Mutations.
    Huang L; Lu J; Wang Y; Sun L; Ding X
    Invest Ophthalmol Vis Sci; 2023 Feb; 64(2):18. PubMed ID: 36790797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bi-allelic mutation of CTNNB1 causes a severe form of syndromic microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia.
    Taylor RL; Soriano CS; Williams S; Dzulova D; Ashworth J; Hall G; Gale T; Lloyd IC; Inglehearn CF; Toomes C; Douzgou S; Black GC
    Orphanet J Rare Dis; 2022 Mar; 17(1):110. PubMed ID: 35246174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTNNB1 (β-CATENIN) VITREORETINOPATHY: IMAGING CHARACTERISTICS AND SURGICAL MANAGEMENT.
    Tipsuriyaporn B; Ammar MJ; Yonekawa Y
    Retin Cases Brief Rep; 2022 May; 16(3):259-262. PubMed ID: 32150115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder.
    Sudnawa KK; Garber A; Cohen R; Calamia S; Kanner CH; Montes J; Bain JM; Fee RJ; Chung WK
    Clin Genet; 2024 May; 105(5):523-532. PubMed ID: 38247296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.
    Arboleda VA; Lee H; Dorrani N; Zadeh N; Willis M; Macmurdo CF; Manning MA; Kwan A; Hudgins L; Barthelemy F; Miceli MC; Quintero-Rivera F; Kantarci S; Strom SP; Deignan JL; ; Grody WW; Vilain E; Nelson SF
    Am J Hum Genet; 2015 Mar; 96(3):498-506. PubMed ID: 25728775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole Exome Sequencing Identified two Novel Truncation Mutations in the
    Ji Y; Xia Q; Zhang H; Huo H; Cao X; Wang W; Gu Q
    Child Neurol Open; 2023; 10():2329048X231184184. PubMed ID: 37560515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.
    Luco SM; Pohl D; Sell E; Wagner JD; Dyment DA; Daoud H
    BMC Med Genet; 2016 Feb; 17():15. PubMed ID: 26922654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTNNB1 gene mutation associated with neurodevelopmental disorder, microcephaly, and persistence of bilateral hyperplastic primary vitreous: A case report and literature review.
    Zuluaga Gómez LM; Caballero Mojica SC; Vélez Rengifo GJ; Bravo Acosta JD; Montoya Villada JH
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Jan; 97(1):44-47. PubMed ID: 35027145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous CTNNB1 and TBX4 variants in a patient with abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity.
    Karolak JA; Szafranski P; Kilner D; Patel C; Scurry B; Kinning E; Chandler K; Jhangiani SN; Coban Akdemir ZH; Lupski JR; Popek E; Stankiewicz P
    Clin Genet; 2019 Oct; 96(4):366-370. PubMed ID: 31309540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: A
    Ke Z; Chen Y
    Front Pediatr; 2020; 8():575673. PubMed ID: 33425807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.